双能CT电子密度诊断非小细胞肺癌转移性纵隔淋巴结:与传统CT及FDG PET/CT表现的比较
回顾性纳入57例非小细胞肺癌患者共117枚手术切除的纵隔淋巴结(33枚转移、84枚非转移),评估双能CT电子密度(ED)诊断转移淋巴结的价值。转移淋巴结ED减低,ED≤3.48×10^23/cm3诊断的敏感度87.9%、特异度58.3%;ED联合短径或FDG阳性摄取准确度最高(82.9%、82.1%),高于单项特征(p<.05)。
要点
- 转移性纵隔淋巴结双能CT电子密度减低,ED≤3.48×10^23/cm3诊断敏感度87.9%、特异度58.3%。
- ED联合短径>8.5 mm准确度82.9%(敏感度54.5%、特异度94.0%),ED联合FDG阳性摄取准确度82.1%。
- 碘浓度在转移与非转移淋巴结间无显著差异(p=.18),未纳入诊断效能分析。
核心结论
- 双能CT衍生的电子密度可能有助于诊断非小细胞肺癌转移性纵隔淋巴结,转移淋巴结ED减低。
- ED可能补充传统CT表现和PET/CT的FDG摄取,用于诊断转移淋巴结。
研究设计与样本
- 回顾性研究纳入57例非小细胞肺癌患者(男36例、女21例,平均年龄68.4±8.9岁),均行术前双能CT和FDG PET/CT并有手术切除的纵隔淋巴结。
- 共分析117枚手术切除的纵隔淋巴结(转移33枚、非转移84枚)。
- 两名放射科医师独立在120-kVp图像上评估淋巴结形态特征,并用双能CT生成的图测量碘浓度和电子密度,分歧经共识解决。
- 另两名放射科医师共识评估FDG PET/CT淋巴结阳性摄取;评估单项特征及两两组合的诊断效能。
关键影像表现/征象
- 转移淋巴结电子密度减低,ED≤3.48×10^23/cm3诊断敏感度87.9%、特异度58.3%、准确度66.7%。
- 存在坏死诊断转移的敏感度15.2%、特异度98.8%、准确度75.2%。
- 短径>8.5 mm诊断敏感度54.5%、特异度85.7%、准确度76.9%;长径>13.0 mm敏感度63.6%、特异度73.8%、准确度70.9%。
- 120-kVp图像衰减≤95.8 HU诊断敏感度51.5%、特异度79.8%、准确度71.8%;FDG阳性摄取敏感度66.7%、特异度75.0%、准确度72.6%。
- 碘浓度在转移与非转移淋巴结间无显著差异(p=.18),未纳入诊断效能分析。
诊断标准与关键数值
- ED≤3.48×10^23/cm3诊断转移淋巴结:敏感度87.9%、特异度58.3%、准确度66.7%。
- 短径>8.5 mm:敏感度54.5%、特异度85.7%、准确度76.9%;长径>13.0 mm:敏感度63.6%、特异度73.8%、准确度70.9%。
- 120-kVp图像衰减≤95.8 HU:敏感度51.5%、特异度79.8%、准确度71.8%;坏死存在:敏感度15.2%、特异度98.8%、准确度75.2%。
- FDG阳性摄取:敏感度66.7%、特异度75.0%、准确度72.6%。
- ED联合短径准确度82.9%(敏感度54.5%、特异度94.0%)、ED联合FDG阳性摄取准确度82.1%(敏感度60.6%、特异度90.5%),高于单项特征(p<.05);其余组合准确度74.4%–77.8%。
临床应用与阅片要点
- ED测量观察者间一致性良好,组内相关系数0.90。
- ED联合短径或FDG阳性摄取可提高诊断准确度,高于单项特征(p<.05)。
- 作者认为ED可能补充传统CT表现和PET/CT的FDG摄取用于诊断转移淋巴结。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Accurate nodal staging is essential to guide treatment selection in patients with non-small cell lung cancer (NSCLC). To our knowledge, measurement of electron density (ED) using dual-energy CT (DECT) is unexplored for this purpose. OBJECTIVE. The purpose of our study was to assess the utility of ED from DECT in diagnosing metastatic mediastinal lymph nodes in patients with NSCLC in comparison with conventional CT and FDG PET/CT. METHODS. This retrospective study included 57 patients (36 men, 21 women; mean age, 68.4 ± 8.9 [SD] years) with NSCLC and surgically resected mediastinal lymph nodes who underwent preoperative DECT and FDG PET/CT. The patients had a total of 117 resected mediastinal lymph nodes (33 metastatic, 84 nonmetastatic). Two radiologists independently reviewed the morphologic features of nodes on the 120-kVp images and also measured the iodine concentration (IC) and ED of nodes using maps generated from DECT data; consensus was reached for discrepancies. Two different radiologists assessed FDG PET/CT examinations in consensus for positive node uptake. Diagnostic performance was evaluated for individual and pairwise combinations of features. RESULTS. The sensitivity, specificity, and accuracy for nodal metastasis were 15.2%, 98.8%, and 75.2% for the presence of necrosis, respectively; 54.5%, 85.7%, and 76.9% for short-axis diameter greater than 8.5 mm; 63.6%, 73.8%, and 70.9% for long-axis diameter greater than 13.0 mm; 51.5%, 79.8%, and 71.8% for attenuation on 120-kVp images of 95.8 HU or less; 87.9%, 58.3%, and 66.7% for ED of 3.48 × 1023/cm3 or less; and 66.7%, 75.0%, and 72.6% for positive FDG uptake. Among pairwise combinations of features, accuracy was highest for the combination of ED and short-axis diameter (accuracy, 82.9%; sensitivity, 54.5%; specificity, 94.0%) and the combination of ED and positive FDG uptake (accuracy, 82.1%; sensitivity, 60.6%; specificity, 90.5%); these accuracies were greater than those for the individual features (p < .05). The remaining combinations exhibited accuracies ranging from 74.4% to 77.8%. Interobserver agreement analysis showed an intraclass correlation coefficient of 0.90 for ED. IC was not significantly different between metastatic and nonmetastatic nodes (p = .18) and was excluded from the diagnostic performance analysis. CONCLUSION. ED derived from DECT may help diagnose metastatic lymph nodes in NSCLC given decreased ED in metastatic nodes. CLINICAL IMPACT. ED may complement conventional CT findings and FDG uptake on PET/CT in diagnosing metastatic nodes.
引用
- Nagano H, Takumi K, Nakajo M, et al. Dual-Energy CT-Derived Electron Density for Diagnosing Metastatic Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: Comparison With Conventional CT and FDG PET/CT Findings. AJR Am J Roentgenol. 2021. PMID: 34319164. doi:10.2214/AJR.21.26208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。